SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
25th Jul 20137:00 amRNSInterim Management Statement
17th Jul 20131:46 pmRNSDirector/PDMR Shareholding
2nd Jul 201310:54 amRNSHolding(s) in Company
2nd Jul 20137:39 amRNSDirector Declaration
28th Jun 20138:00 amRNSTotal Voting Rights
26th Jun 20139:35 amRNSHolding(s) in Company
25th Jun 201310:43 amRNSHolding(s) in Company
24th Jun 20132:33 pmRNSHolding(s) in Company
21st Jun 20139:13 amRNSHolding(s) in Company
18th Jun 20134:41 pmRNSDirector/PDMR Shareholding
7th Jun 201312:26 pmRNSHolding(s) in Company
5th Jun 20132:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20131:50 pmRNSBlocklisting Interim Review
31st May 20131:49 pmRNSTotal Voting Rights
28th May 20139:02 amRNSHolding(s) in Company
28th May 20137:00 amRNSHalf Yearly Report
20th May 20133:34 pmRNSHolding(s) in Company
17th May 20131:39 pmRNSDirector/PDMR Shareholding
16th May 201310:35 amRNSHolding(s) in Company
14th May 20139:58 amRNSHolding(s) in Company
30th Apr 20133:53 pmRNSTotal Voting Rights
24th Apr 20134:24 pmRNSHolding(s) in Company
22nd Apr 20134:14 pmRNSHolding(s) in Company
22nd Apr 20134:02 pmRNSHolding(s) in Company
17th Apr 20131:54 pmRNSDirector/PDMR Shareholding
16th Apr 20134:34 pmRNSHolding(s) in Company
9th Apr 20137:00 amRNSTrading Statement
3rd Apr 20133:01 pmRNSHolding(s) in Company
28th Mar 20133:00 pmRNSTotal Voting Rights
22nd Mar 20139:51 amRNSHolding(s) in Company
21st Mar 201310:25 amRNSHolding(s) in Company
20th Mar 201312:28 pmRNSDirector/PDMR Shareholding
13th Mar 201312:20 pmRNSHolding(s) in Company
28th Feb 20133:19 pmRNSTotal Voting Rights
28th Feb 20132:49 pmRNSDirector/PDMR Shareholding
27th Feb 201311:05 amRNSHolding(s) in Company
26th Feb 20139:32 amRNSHolding(s) in Company
20th Feb 201311:38 amRNSDirector/PDMR Shareholding
5th Feb 20134:24 pmRNSResult of AGM
5th Feb 20137:00 amRNSAGM and Interim Management Statement
4th Feb 201311:42 amRNSHolding(s) in Company
31st Jan 201312:47 pmRNSTotal Voting Rights
29th Jan 201312:46 pmRNSHolding(s) in Company
23rd Jan 201312:23 pmRNSHolding(s) in Company
17th Jan 20134:13 pmRNSDirector/PDMR Shareholding
8th Jan 201310:24 amRNSHolding(s) in Company
7th Jan 20132:40 pmRNSAnnual Information Update
7th Jan 20132:02 pmRNSAnnual Financial Report
7th Jan 201312:37 pmRNSHolding(s) in Company
28th Dec 201212:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.